{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T03:48:58Z","timestamp":1761968938756,"version":"build-2065373602"},"reference-count":40,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":3876,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1038\/modpathol.2012.1","type":"journal-article","created":{"date-parts":[[2012,2,10]],"date-time":"2012-02-10T07:45:01Z","timestamp":1328859901000},"page":"805-814","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["BCL2 expression in CD105 positive neoangiogenic cells and tumor progression in angioimmunoblastic T-cell lymphoma"],"prefix":"10.1016","volume":"25","author":[{"given":"Philippe","family":"Ratajczak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christophe","family":"Leboeuf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josette","family":"Bri\u00e8re","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irmine","family":"Loisel-Ferreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Thi\u00e9blemont","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Li","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Janin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1038\/modpathol.2012.1_bib1","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1097\/01.cco.0000181404.83084.b5","article-title":"Angiogenesis in malignant lymphoma","volume":"17","author":"Koster","year":"2005","journal-title":"Curr Opin Oncol"},{"key":"10.1038\/modpathol.2012.1_bib2","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/sj.bjc.6600742","article-title":"Vascular patterns in reactive lymphoid tissue and in non-Hodgkin\u2019s lymphoma","volume":"88","author":"Passalidou","year":"2003","journal-title":"Br J Cancer"},{"key":"10.1038\/modpathol.2012.1_bib3","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1038\/labinvest.3700145","article-title":"Vascular endothelial growth factor-A is expressed both on lymphoma cells and endothelial cells in angioimmunoblastic T-cell lymphoma and related to lymphoma progression","volume":"84)","author":"Zhao","year":"2004","journal-title":"Lab Invest"},{"key":"10.1038\/modpathol.2012.1_bib4","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1093\/annonc\/mdm579","article-title":"Complete response of relapsed angioimmunoblastic T-cell lymphoma following therapy with bevacizumab","volume":"19","author":"Aguiar Bujanda","year":"2008","journal-title":"Ann Oncol"},{"key":"10.1038\/modpathol.2012.1_bib5","first-page":"899","article-title":"Evaluation and management of angioimmunoblastic T-cell lymphoma: a review of current approaches and future strategies","volume":"6","author":"Alizadeh","year":"2008","journal-title":"Clin Adv Hematol Oncol"},{"key":"10.1038\/modpathol.2012.1_bib6","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1038\/sj.leu.2403936","article-title":"Complete remission in a patient with relapsed angioimmunoblastic T-cell lymphoma following treatment with bevacizumab","volume":"19","author":"Bruns","year":"2005","journal-title":"Leukemia"},{"key":"10.1038\/modpathol.2012.1_bib7","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1097\/MOH.0b013e328186ffbf","article-title":"Angioimmunoblastic T cell lymphoma: pathobiological insights and clinical implications","volume":"14","author":"Dunleavy","year":"2007","journal-title":"Curr Opin Hematol"},{"key":"10.1038\/modpathol.2012.1_bib8","doi-asserted-by":"crossref","first-page":"9685","DOI":"10.1158\/0008-5472.CAN-07-1497","article-title":"BCL2 orchestrates a cross-talk between endothelial and tumor cells that promotes tumor growth","volume":"67","author":"Kaneko","year":"2007","journal-title":"Cancer Res"},{"key":"10.1038\/modpathol.2012.1_bib9","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/labinvest.2008.46","article-title":"Endothelial cells expressing BCL2 promotes tumor metastasis by enhancing tumor angiogenesis, blood vessel leakiness and tumor invasion","volume":"88","author":"Kumar","year":"2008","journal-title":"Lab Invest"},{"key":"10.1038\/modpathol.2012.1_bib10","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.bbrc.2010.03.102","article-title":"Hypoxia-induced BCL2 expression in endothelial cells via p38 MAPK pathway","volume":"394","author":"Zhang","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1038\/modpathol.2012.1_bib11","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1158\/0008-5472.CAN-06-2265","article-title":"BCL2 protects endothelial cells against gamma-radiation via a Raf-MEK-ERK-survivin signaling pathway that is independent of cytochrome c release","volume":"67","author":"Kumar","year":"2007","journal-title":"Cancer Res"},{"key":"10.1038\/modpathol.2012.1_bib12","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1158\/1078-0432.CCR-08-2610","article-title":"G3139, an anti-BCL2 antisense oligomer that binds heparin-binding growth factors and collagen I, alters in vitro endothelial cell growth and tubular morphogenesis","volume":"15","author":"Stein","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1038\/modpathol.2012.1_bib13","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1093\/cvr\/cvp332","article-title":"Targeting cancer vasculature via endoglin\/CD105: a novel antibody-based diagnostic and therapeutic strategy in solid tumours","volume":"86","author":"Fonsatti","year":"2010","journal-title":"Cardiovasc Res"},{"key":"10.1038\/modpathol.2012.1_bib14","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s00401-007-0251-4","article-title":"Density of microvessels positive for CD105 (endoglin) is related to prognosis in meningiomas","volume":"114","author":"Barresi","year":"2007","journal-title":"Acta Neuropathol"},{"key":"10.1038\/modpathol.2012.1_bib15","first-page":"417","article-title":"Endoglin is a better marker than CD31 in evaluation of angiogenesis in glioblastoma","volume":"46","author":"Behrem","year":"2005","journal-title":"Croat Med J"},{"key":"10.1038\/modpathol.2012.1_bib16","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1007\/s00428-006-0195-4","article-title":"Endoglin (CD105) as a prognostic factor in head and neck squamous cell carcinoma","volume":"448","author":"Kyzas","year":"2006","journal-title":"Virchows Arch"},{"key":"10.1038\/modpathol.2012.1_bib17","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s11060-006-9281-3","article-title":"Endoglin (CD 105) is expressed on endothelial cells in the primary central nervous system lymphomas and correlates with survival","volume":"82","author":"Sugita","year":"2007","journal-title":"J Neurooncol"},{"key":"10.1038\/modpathol.2012.1_bib18","unstructured":"Swerdlow SH, Campo E, Harris NL, et al. WHO classification of tumours of hematopoietic and lymphoid tissues. 4th edn., IARC, 2008, pp 309\u2013311."},{"key":"10.1038\/modpathol.2012.1_bib19","doi-asserted-by":"crossref","first-page":"545","DOI":"10.3109\/10428199909058412","article-title":"Angioimmunoblastic-like T-cell non Hodgkin\u2019s lymphoma: outcome after chemotherapy in 33 patients and review of the literature","volume":"32","author":"Pautier","year":"1999","journal-title":"Leuk Lymphoma"},{"key":"10.1038\/modpathol.2012.1_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM199101033240101","article-title":"Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma","volume":"324","author":"Weidner","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1038\/modpathol.2012.1_bib21","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/S0959-8049(02)00094-1","article-title":"Second international consensus on the methodology and criteria of evaluation of angiogenesis quantification in solid human tumours","volume":"38","author":"Vermeulen","year":"2002","journal-title":"Eur J Cancer"},{"key":"10.1038\/modpathol.2012.1_bib22","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1016\/S0959-8049(96)00379-6","article-title":"Quantification of angiogenesis in solid human tumours: an international consensus on the methodology and criteria of evaluation","volume":"32A","author":"Vermeulen","year":"1996","journal-title":"Eur J Cancer"},{"key":"10.1038\/modpathol.2012.1_bib23","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1111\/j.1365-2141.2008.07534.x","article-title":"Angiogenic mediators of the angiopoietin system are highly expressed by CD10-positive lymphoma cells in angioimmunoblastic T-cell lymphoma","volume":"144","author":"Konstantinou","year":"2009","journal-title":"Br J Haematol"},{"key":"10.1038\/modpathol.2012.1_bib24","doi-asserted-by":"crossref","first-page":"356","DOI":"10.3324\/haematol.2009.019133","article-title":"A novel subset of T-helper cells: follicular T-helper cells and their markers","volume":"95","author":"Laurent","year":"2010","journal-title":"Haematologica"},{"key":"10.1038\/modpathol.2012.1_bib25","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1200\/JCO.2005.03.6327","article-title":"Marker expression in peripheral T-cell lymphoma: a proposed clinical-pathologic prognostic score","volume":"24","author":"Went","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1038\/modpathol.2012.1_bib26","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/jid.2008.430","article-title":"Bcl-xL gene expression correlated with lower apoptotic cell numbers and shorter progression-free survival in PCFCL","volume":"129","author":"Soltani-Arabshahi","year":"2009","journal-title":"J Invest Dermatol"},{"key":"10.1038\/modpathol.2012.1_bib27","first-page":"987","article-title":"The International Non-Hodgkin\u2019s Lymphoma Prognostic Factors Project","volume":"329","author":"A predictive model for aggressive non-Hodgkin\u2019s lymphoma","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1038\/modpathol.2012.1_bib28","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1111\/j.1365-2133.2003.05649.x","article-title":"BCL2, Bcl-6 and CD10 expression in cutaneous B-cell lymphoma: further support for a follicle centre cell origin and differential diagnostic significance","volume":"149","author":"Hoefnagel","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1038\/modpathol.2012.1_bib29","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s00277-006-0127-z","article-title":"Clinical role of BCL2, Bax, or p53 overexpression in peripheral T-cell lymphomas","volume":"85","author":"Jung","year":"2006","journal-title":"Ann Hematol"},{"key":"10.1038\/modpathol.2012.1_bib30","doi-asserted-by":"crossref","first-page":"C1521","DOI":"10.1152\/ajpcell.90633.2007","article-title":"Attenuation of retinal endothelial cell migration and capillary morphogenesis in the absence of BCL2","volume":"294","author":"Kondo","year":"2008","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1038\/modpathol.2012.1_bib31","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1038\/sj.cdd.4402174","article-title":"Unidirectional crosstalk between Bcl-xL and BCL2 enhances the angiogenic phenotype of endothelial cells","volume":"14","author":"Karl","year":"2007","journal-title":"Cell Death Differ"},{"key":"10.1038\/modpathol.2012.1_bib32","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1073\/pnas.0408357102","article-title":"Induction, differentiation, and remodeling of blood vessels after transplantation of BCL2-transduced endothelial cells","volume":"102","author":"Enis","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/modpathol.2012.1_bib33","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1080\/10623320802092393","article-title":"Antiapoptotic activities of BCL2 correlate with vascular maturation and transcriptional modulation of human endothelial cells","volume":"15","author":"Enis","year":"2008","journal-title":"Endothelium"},{"key":"10.1038\/modpathol.2012.1_bib34","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0002-9440(10)65284-4","article-title":"Vascular endothelial growth factor (VEGF)-mediated angiogenesis is associated with enhanced endothelial cell survival and induction of BCL2 expression","volume":"154","author":"Nor","year":"1999","journal-title":"Am J Pathol"},{"key":"10.1038\/modpathol.2012.1_bib35","first-page":"2183","article-title":"Up-Regulation of BCL2 in microvascular endothelial cells enhances intratumoral angiogenesis and accelerates tumor growth","volume":"61","author":"Nor","year":"2001","journal-title":"Cancer Res"},{"key":"10.1038\/modpathol.2012.1_bib36","first-page":"856","article-title":"Breast carcinoma: vascular density determined using CD105 antibody correlates with tumor prognosis","volume":"59","author":"Kumar","year":"1999","journal-title":"Cancer Res"},{"key":"10.1038\/modpathol.2012.1_bib37","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1002\/pros.10083","article-title":"Endoglin (CD105) is expressed on immature blood vessels and is a marker for survival in prostate cancer","volume":"51","author":"Wikstrom","year":"2002","journal-title":"Prostate"},{"key":"10.1038\/modpathol.2012.1_bib38","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1096\/fj.02-0634rev","article-title":"CD105 is important for angiogenesis: evidence and potential applications","volume":"17","author":"Duff","year":"2003","journal-title":"FASEB J"},{"key":"10.1038\/modpathol.2012.1_bib39","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1038\/nature04478","article-title":"Angiogenesis in life, disease and medicine","volume":"438","author":"Carmeliet","year":"2005","journal-title":"Nature"},{"key":"10.1038\/modpathol.2012.1_bib40","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1056\/NEJMoa0802885","article-title":"Stromal gene signatures in large-B-cell lymphomas","volume":"359","author":"Lenz","year":"2008","journal-title":"N Engl J Med"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/modpathol20121.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/modpathol20121","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222015988?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222015988?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/modpathol20121.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T00:49:54Z","timestamp":1760230194000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395222015988"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["S0893395222015988"],"URL":"https:\/\/doi.org\/10.1038\/modpathol.2012.1","relation":{},"ISSN":["0893-3952"],"issn-type":[{"type":"print","value":"0893-3952"}],"subject":[],"published":{"date-parts":[[2012,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"BCL2 expression in CD105 positive neoangiogenic cells and tumor progression in angioimmunoblastic T-cell lymphoma","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/modpathol.2012.1","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2012 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}